Zenith Drugs Limited

₹38.70As of Sun 8 Nov 2026, 12:00 UTC
NSE:ZENITHDRUGHealthcare
Country India
PE (Fwd) •••
TSR 3Y CAGR (28.50%)
Div yield —
ROE 5.53%
Medical (Pharmaceuticals)
Beta (5Y) 1.39
PE TTM 16.83
TSR TTM (40.51%)
Mkt cap ₹663.7M
ROIC 5.53%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹49
27.39%
435.61%
Hold 11|11|8|7|12
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.61
0.66
0.64
0.69
35.02%
32.22%
29.54%
25.47%
Revenue₹M
43.67
43.60
45.63
47.59
4.82%
6.59%
9.98%
9.41%
Peers (US$7.067M)
Cap (US$)
PE
14.80M
9.350x
8.858M
43.29x
Capital
TTM
5Y
10Y
Leveragex
0.724
0.068
0.052
EBIT/Intx
0.843
0.163
0.164
Own earn%
58.22
(15.37)
(11.92)
Sh yield%
23.78
16.10
19.95
Owners
Insiders/Inst%
8.89
49.40
Short interest%
5.16
SBC / revenue%
5.52
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
7–11
$1 testx
—
Incr. ROIC%
20